Toggle Main Menu Toggle Search

Open Access padlockePrints

TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation

Lookup NU author(s): Dr Catherine Drummond, Arman Esfandiari, Dr Xiaohong Lu, Dr Claire Hutton, Dr Jennifer Jackson, Dr Karim Bennaceur, Qing Xu, Professor Herbie Newell, Dr Ian HardcastleORCiD, Professor Roger Griffin, Professor John LunecORCiD



This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Drummond CJ, Esfandiari A, Liu J, Lu X, Hutton C, Jackson J, Bennaceur K, Xu Q, Makimanejavali AR, Bello FD, Piergentili A, Newell DR, Hardcastle IR, Griffin RJ, Lunec J

Publication type: Article

Publication status: Published

Journal: Oncotarget

Year: 2016

Volume: 7

Issue: 29

Pages: 46203-46218

Online publication date: 15/06/2016

Acceptance date: 29/05/2016

Date deposited: 04/07/2016

ISSN (electronic): 1949-2553

Publisher: Impact Journals LLC


DOI: 10.18632/oncotarget.10073


Altmetrics provided by Altmetric


Funder referenceFunder name
C240/A15751Cancer Research UK
C27826/A11524Cancer Research UK
C0190R4011Newcastle University & Northern Institute for Cancer Research
RES0190/7368DePPICT FP6 Commission of the European Communities Programme